Welcome to
Acute Myeloid Leukemia (AML): Treatment Options, Including BMT, Care & Support
Tuesday, June 19, 2018
Baltimore Country Club
4712 Club Road, Baltimore, MD, 21210
Registration: 6:00pm-6:30pm
Program: 6:30pm-7:30pm
Complimentary dinner will be provided.
Continuing Education Information:
Goal: To educate hematology, oncology and BMT nurses and social workers, on the treatment options and support of AML. Objectives : At the conclusion of this program, participants will be able to:
Identify diagnostic tests included in AML panels, including the role of cytogenetics and molecular analysis. Describe risk stratification for treatment planning. Identify approved and emerging treatment options and the role of clinical trials for the treatment of AML. Explain the impact of timely blood and marrow transplantation (BMT) referral. List programs and resources to support patients with acute myeloid leukemia and their caregivers.
Target Audience: Oncology nurses and social workers at all levels and licensure, and other healthcare professionals involved in the treatment of patients with AML.
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1 continuing education contact hours through the California Board of Registered Nursing.
The Leukemia & Lymphoma Society (LLS), provider #1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: December 2017 - December 2020. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1 CE clinical contact hours.
Upon completion of this
program and submission of the activity evaluation, a certificate of
completion will be emailed to you within 30 days.
Speaker:
Maria Baer, M.D.
Professor of Medicine and Molecular Medicine
T o register, please click on the REGISTER tab above.
